[The association of high-sensitivity C-reactive protein with new-onset hypertension in different age groups]

Z M Guo1, J H Wu1, X Y Li2

  • 1Graduate School of North China University of Science and Technology, Tangshan 063000, China.

Insights

Elevated high-sensitivity C-reactive protein (hsCRP) levels increase the risk of developing new-onset hypertension. This association is more pronounced in younger age groups, indicating an age-dependent risk.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biomarkers
  • Epidemiology

Context:

  • Hypertension is a major global health concern with complex risk factors.
  • Inflammation, indicated by high-sensitivity C-reactive protein (hsCRP), is increasingly recognized as a contributor to cardiovascular disease.
  • Understanding the relationship between hsCRP and hypertension across different age demographics is crucial for targeted prevention strategies.

Purpose:

  • To examine the association between baseline hsCRP levels and the incidence of new-onset hypertension.
  • To investigate whether this association varies across different age strata.
  • To quantify the risk of developing hypertension associated with elevated hsCRP levels in a prospective cohort.

Summary:

  • A prospective cohort study of 51,179 non-hypertensive adults followed for 8.1 years found that higher hsCRP levels were associated with an increased risk of new-onset hypertension.
  • The risk of developing hypertension was significantly higher in the high-risk hsCRP group (hsCRP > 3.0 mg/L) compared to the low-risk group (hsCRP < 1.0 mg/L), with a hazard ratio of 1.11.
  • This association was age-dependent, with a stronger risk observed in younger age groups (<45, 45-54, 55-64 years) compared to those aged 65 and older.

Impact:

  • Identifies hsCRP as a significant, age-dependent risk factor for incident hypertension.
  • Suggests that hsCRP levels could aid in risk stratification for hypertension, particularly in middle-aged populations.
  • Highlights the need for considering inflammatory markers in hypertension prevention and management strategies, tailored by age.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
39
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
164
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
49
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
51